Literature DB >> 7908630

Irreversible binding to proteins after single and repeated daily oral administration of 4-(2,2-diphenylethyl) imidazole (SC-46264) to the Cynomolgus monkey.

P Jacqmin1, M Hérin, R Cavalier, M Lesne.   

Abstract

SC-46264 is an antagonist of the alpha 2-adrenergic receptor. Distribution and excretion of [14C]-SC-46264 were studied after single and repeated daily oral administrations to the Cynomolgus monkey at a 1.5 mg/kg dose. After a single oral administration, more than 95% of the administered dose was recovered within 48 h in the urine (+/- 60%) and faeces (+/- 40%). Approximately 1.7% remained in the gastro-intestinal (GI) tract and 2% in the animal body. However, the radioactivity remaining in the animal body decreased very slowly from 2 to 1% between 48 and 144 h. An accumulation of very small amounts of radioactivity could be suspected in the plasma, the liver, the thyroid, the adrenals and the kidneys. In a 2 week daily oral administration of [14C]-SC-46264, the amount of total radioactivity remaining in the animal body 24, 48 and 216 h after the last administration was approximately 21, 11 and 5% of the daily administered dose, respectively. It confirmed the accumulation of [14C]-SC-46264 related compound in the plasma, the liver, the thyroid, the adrenals and the kidneys. The minimum plasma concentrations of total radioactivity observed before each administration increased during the treatment and apparently did not yet reach an equilibrium after 14 days. In these plasma samples obtained throughout the study, an increasing fraction of the total radioactivity could not be extracted and was recovered with precipitable material. These observations lead to the hypothesis of an irreversible binding of some material to the proteins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7908630     DOI: 10.1007/BF03188812

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  5 in total

1.  Conversion of phenytoin to reactive metabolites in rat liver microsomes.

Authors:  R E Billings; S G Milton
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

2.  Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age, and sex in rats and mice.

Authors:  D Roy; W R Snodgrass
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1988-02

3.  In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.

Authors:  S Kubow; P G Wells
Journal:  Mol Pharmacol       Date:  1989-04       Impact factor: 4.436

4.  Comparative studies of the in vitro metabolism and covalent binding of 14C-benzene by liver slices and microsomal fraction of mouse, rat, and human.

Authors:  J I Brodfuehrer; D E Chapman; T J Wilke; G Powis
Journal:  Drug Metab Dispos       Date:  1990 Jan-Feb       Impact factor: 3.922

5.  An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.

Authors:  R J Riley; J L Maggs; C Lambert; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.